IFNB1 and myasthenia gravis: The Experimental Autoimmune Myasthenia Gravis mouse model suggests that a decrease in miR-29a/b1 could promote the upregulation of IFN-β and the formation of pro-inflammatory Th17 cells, potentially influencing MG susceptibility.